Anagram Therapeutics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 38

Employees

  • Latest Deal Type
  • PE Growth

  • Financing Rounds
  • 6

Anagram Therapeutics General Information

Description

Developer of orally-delivered enzyme therapeutics designed for the treatment of rare, life-threatening diseases. The company leverages proprietary enzyme technologies and expertise in gastrointestinal diseases, treats malabsorption syndromes and nutrient metabolism disorders that prevent the body from properly processing or absorbing certain fats, sugars, proteins, vitamins, or other key nutrients, enabling medical practitioners to address a major unmet need associated with the treatment of malabsorption and exocrine pancreatic insufficiency.

Contact Information

Formerly Known As
Synspira Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 33 Strathmore Road
  • Natick, MA 01760
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 33 Strathmore Road
  • Natick, MA 01760
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Anagram Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anagram Therapeutics‘s full profile, request access.

Request a free trial

Anagram Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of orally-delivered enzyme therapeutics designed for the treatment of rare, life-threatening diseases. The com
Drug Discovery
Natick, MA
38 As of 2026

Cambridge, MA
 

Framingham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Anagram Therapeutics Competitors (87)

One of Anagram Therapeutics’s 87 competitors is Casma Therapeutics, a Venture Capital-Backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Casma Therapeutics Venture Capital-Backed Cambridge, MA
Alzheon Venture Capital-Backed Framingham, MA
Regenerx Formerly VC-backed Rockville, MD
Glycomine Venture Capital-Backed San Carlos, CA
AnTolRx Formerly VC-backed Cambridge, MA
You’re viewing 5 of 87 competitors. Get the full list »

Anagram Therapeutics Patents

Anagram Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2025209470-A1 Methods and compositions for treating congenital sucrase-isomaltase deficiency Pending 17-Jan-2024
WO-2025155915-A1 Methods and compositions for treating congenital sucrase-isomaltase deficiency Pending 17-Jan-2024
AU-2023305628-A1 Methods and compositions for treating congenital sucrase-isomaltase deficiency Pending 13-Jul-2022
EP-4555081-A1 Methods and compositions for treating congenital sucrase-isomaltase deficiency Pending 13-Jul-2022
EP-4555081-A4 Methods and compositions for treating congenital sucrase-isomaltase deficiency Pending 13-Jul-2022 C12N9/2451
To view Anagram Therapeutics’s complete patent history, request access »

Anagram Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Anagram Therapeutics Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Anagram Therapeutics‘s full profile, request access.

Request a free trial

Anagram Therapeutics FAQs

  • When was Anagram Therapeutics founded?

    Anagram Therapeutics was founded in 2017.

  • Where is Anagram Therapeutics headquartered?

    Anagram Therapeutics is headquartered in Natick, MA.

  • What is the size of Anagram Therapeutics?

    Anagram Therapeutics has 38 total employees.

  • What industry is Anagram Therapeutics in?

    Anagram Therapeutics’s primary industry is Drug Discovery.

  • Is Anagram Therapeutics a private or public company?

    Anagram Therapeutics is a Private company.

  • What is the current valuation of Anagram Therapeutics?

    The current valuation of Anagram Therapeutics is .

  • What is Anagram Therapeutics’s current revenue?

    The current revenue for Anagram Therapeutics is .

  • How much funding has Anagram Therapeutics raised over time?

    Anagram Therapeutics has raised $278M.

  • Who are Anagram Therapeutics’s investors?

    Blackstone, Miller Family Wine Brands, Cystic Fibrosis Foundation, and ABI LAB have invested in Anagram Therapeutics.

  • Who are Anagram Therapeutics’s competitors?

    Casma Therapeutics, Alzheon, Regenerx, Glycomine, and AnTolRx are some of the 87 competitors of Anagram Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process